Evaluation Cholesterol and Triglycerides Levels for Type One Diabetes Patients
Abstract
This study is designed to highlight the association between high level of blood glucose and cholesterol and triglycerides. Thirty persons divided into six groups according to age. Groups A, B, C, D, E are patients groups that compared with the control group N. Three blood biomedical parameters were assessed in the current study that including random blood sugar (RBS), cholesterol and triglycerides levels. Statistical analysis showed significant differences between control group and patients' groups. Also, analysis confirmed a strong relation between glucose levels and cholesterol and triglycerides levels respectively. These results confirm the scientific recommendations about the life style, diabetes management and eating habits
Keywords:
Diabetes, Cholesterol, Triglyceride, Hyperglycaemia, Deslipidemia
Downloads
Download data is not yet available.
References
1. F. Gao, C.Y. Cui, Dietary cholesterol intake and risk of gestational diabetes mellitus: a meta-analysis of observational studies. Journal of the American Nutrition Association, (2022) 41(1), 107-115.
2. E. Oktaviana, B. Nadrati, A. Fitriani, Analysis of the Relationship of Blood Glucose Levels with Total Cholesterol and Age of Diabetes Mellitus Patients. International Journal of Nursing and Health Services, (2022) 5(2), 195-202.
3. Y. Shan, Y., Q. Wang, Q., Y. Zhang, Y., X. Tong, X., S. Pu, S., Y. Xu, Y., X. Gao, High remnant cholesterol level is relevant to diabetic retinopathy in type 2 diabetes mellitus. Lipids in health and disease, (2022) 21(1), 1-10.
4. I. H. Seo, I. H., D. H. Son, D. H., H. S. Lee, H. S., Y. J. Lee, Non-HDL cholesterol as a predictor for incident type 2 diabetes in community-dwelling adults: longitudinal findings over 12 years. Translational Research, (2022) 243, 52-59.
5. G. Yang, G., T. Qian, T., H. Sun, H., Q. Xu, Q., X. Hou, X., W. Hu, Y. Wang, Both low and high levels of low-density lipoprotein cholesterol are risk factors for diabetes diagnosis in Chinese adults. Diabetes Epidemiology and Management, (2022) 100050.
6. G. Ouchi, G., I. Komiya, I., S. Taira, S., T. Wakugami, Y. Ohya, Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients. Lipids in Health and Disease, (2022) 21(1), 1-12.
7. C. I. Mercado, K. McKeever Bullard, E. W. Gregg, M. K. Ali, S. H. Saydah, G. Imperatore, Differences in US Rural-Urban Trends in Diabetes ABCS, 1999–2018. Diabetes Care, (2021) 44(8), 1766-1773.
8. M. M. Pathirana, Z. Lassi, A. Ali, M. Arstall, C. T. Roberts, P. H. Andraweera, Cardiovascular risk factors in women with previous gestational diabetes mellitus: A systematic review and meta- analysis. Reviews in Endocrine and Metabolic Disorders, (2021) 22(4), 729-761.
9. C. Perego, L. Da Dalt, A. Pirillo, A. Galli, A. L. Catapano, G. D. Norata, Cholesterol metabolism, pancreatic β-cell function and diabetes. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, (2019) 1865(9), 2149-2156.
10. Q. Zhang, Q., M. Zhang, M., Y. Chen, Y., Y. Cao, Y., G. Dong, Nonlinear Relationship of Non- High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011–2014). Journal of Alzheimer's Disease, (Preprint), (2022) 1-10.
11. F. Chen, F., B. Liu, Sleeve gastrectomy suppresses hepatic de novo cholesterogenesis and improves hepatic cholesterol accumulation in obese rats with type 2 diabetes mellitus. Nutrition, (2022) 94, 111531.
12. J. J. Belch, M. Brodmann, I. Baumgartner, C. J. Binder, M. Casula, C. Heiss, L. Tokgözoğlu, Lipid- lowering and anti-thrombotic therapy in patients with peripheral arterial disease. Vasa, (2021) 50(6), 401-411.
13. N. G. Gogolashvili, R. A. Yaskevich, Effectiveness of lipid-lowering therapy in outpatients with coronary artery disease living in a large industrial center of Eastern Siberia. Journal: Cardiovascular Therapy and Prevention, (2022) (8), 3135.
14. T. Onat, M. Demir Caltekin, V. A. Turksoy, E. Baser, D. Aydogan Kirmizi, M. Kara, E. S. Yalvac, The relationship between heavy metal exposure, trace element level, and monocyte to HDL cholesterol ratio with gestational diabetes mellitus. Biological Trace Element Research, (2021) 199(4), 1306-1315.
15. C. Caussy, A. Aubin, R. Loomba, The relationship between type 2 diabetes, NAFLD, and cardiovascular risk. Current diabetes reports, (2021) 21(5), 1-13.
16. Y. H. Seo, H. Y. Shin, Relationship between hs-CRP and HbA1c in Diabetes Mellitus Patients: 2015–2017 Korean National Health and Nutrition Examination Survey. Chonnam medical journal, (2021) 57(1), 62.
17. M. Shi, C. Wang, H. Mei, M. Temprosa, J. C. Florez, M. Tripputi, Diabetes Prevention Program Research Group. Genetic Architecture of Plasma Alpha‐Aminoadipic Acid Reveals a Relationship with High‐Density Lipoprotein Cholesterol. Journal of the American Heart Association, (2021) e024388.
18. H. Hussain, F. H. Wattoo, M. H. S. Wattoo, M. Gulfraz, T. Masud, I. Shah, S. E. Alavi, Camel milk as an alternative treatment regimen for diabetes therapy. Food Science & Nutrition, (2021) 9(3), 1347- 1356.
19. T. Qian, H. Sun, Q. Xu, et al. J Hum Hypertens, 35 (11):1020–8 (2021).
20. E. M. Yubero-Serrano, J. F. Alcalá-Diaz, F. M. Gutierrez-Mariscal, A. P. Arenas-de Larriva, P. J. Peña-Orihuela, R. Blanco-Rojo, J. Lopez-Miranda, Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study. Cardiovascular Diabetology, (2021) 20(1), 1-10.
21. A. von Eckardstein, Beyond HDL-Cholesterol: The Search for Functional Biomarkers of High Density Lipoproteins. CardioMetabolic Syndrome Journal, (2022) 2(1), 28-38.
22. D. Flood, J. A. Seiglie, M. Dunn, S. Tschida, M. Theilmann, M. E. Marcus, J. Manne-Goehler, The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults. The Lancet Healthy Longevity, (2021) 2(6), e340-e351.
23. T. Hidayat, B. Wiboworini, The Effect of Nutrition Support of Commercial Formula and FortemDia_Tri on Total Cholesterol Level and Blood Pressure in Type 2 Diabetes Mellitus Patients. In International Conference on Health and Medical Sciences (2021), 71-76. Atlantis Press.
24. Y. Ikegami, Y. Takenaka, D. Saito, A. Shimada, I. Inoue, Anagliptin Monotherapy for Six Months in Patients with Type 2 Diabetes Mellitus and Hyper-Low-Density Lipoprotein Cholesterolemia Reduces Plasma Levels of Fasting Low-Density Lipoprotein Cholesterol and Lathosterol: A Single- Arm Intervention Trial. Journal of Clinical Medicine Research, (2021) 13(10-11), 502.
25. R. Gupta., A. Ghosh., A. S. Kumar., A. Misra., Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Clinical Research & Reviews, (2020) vol. 14, no. 3, pp. 211-212.
26. A. S. Xiang, B. A. Kingwell, Rethinking good cholesterol: a clinicians' guide to understanding HDL. The Lancet Diabetes & Endocrinology, (2019) 7(7), 575-582.
27. E. M. Yubero-Serrano, J. F. Alcalá-Diaz, F. M. Gutierrez-Mariscal, A. P. Arenas-de Larriva, P. J. Peña-Orihuela, R. Blanco-Rojo, J. Lopez-Miranda, Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study. Cardiovascular Diabetology, (2021) 20(1), 1-10.
28. S. A. Husen, S. P. A. Wahyuningsih, A. N. M. Ansori, S. Hayaza, R. J. K. Susilo, W. Darmanto, D. Winarni, The effect of okra (Abelmoschus esculentus Moench) pods extract on malondialdehyde and cholesterol level in STZ-induced diabetic mice. Ecology, Environment and Conservation, (2019) 25(4), S50-S56.
29. T. Jojima, S. Sakurai, S. Wakamatsu, T. Iijima, M. Saito, T. Tomaru, Y. Aso, Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol. International Journal of Cardiology, (2021) 331, 243-248.
30. A. Viktorinova, D. Malickova, K. Svitekova, S. Choudhury, M. Krizko, Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes. Diabetes Research and Clinical Practice, (2021) 176, 108858.
31. S. Lee, J. Zhou, C. L. Guo, W. T. Wong, T., Liu, I. C. K. Wong, G. Tse, Predictive scores for identifying patients with type 2 diabetes mellitus at risk of acute myocardial infarction and sudden cardiac death. Endocrinology, diabetes & metabolism, (2021) 4(3), e00240.
32. M. Z. Kocak, G. Aktas, E. Erkus, I. Sincer, B. Atak, T. Duman, Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Revista da Associação Médica Brasileira, (2019) 65, 9-15.
33. R. Amelia, M. D. Sari, V. Virgayanti, R. A. Ariga, M. S. Harahap, Effect of duration of illness and lipid profile of type 2 Diabetes Mellitus patients on diabetic retinopathy. In IOP Conference Series: Earth and Environmental Science, (2021) (Vol. 713, No. 1, p. 012058). IOP Publishing.
34. P. Zhuang, F. Wu, L. Mao, F. Zhu, Y. Zhang, X. Chen, Y. Zhang, Egg and cholesterol consumption and mortality from cardiovascular and different causes in the United States: A population-based cohort study. PLoS medicine, (2021) 18(2), e1003508.
35. B. Rathsman, J. Haas, M. Persson, J. Ludvigsson, A. M. Svensson, M. Lind, T. Nyström, LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study. Journal of internal medicine, (2021) 289(6), 873-886.
36. H. Zhao, C. Zheng, M. Zhang, S. Chen, The relationship between vitamin D status and islet function in patients with type 2 diabetes mellitus. BMC endocrine disorders, (2021) 21(1), 1-7.
37. B. J. Cochran, K. L. Ong, B. Manandhar, K. A. Rye, High density lipoproteins and diabetes. Cells, (2021). 10(4), 850.
38. S. U. Khan, H. Rahman, V. Okunrintemi, H. Riaz, M. S. Khan, S. Sattur, M. J. Blaha, Association of lowering low‐density lipoprotein cholesterol with contemporary lipid‐lowering therapies and risk of diabetes mellitus: a systematic review and meta‐analysis. Journal of the American Heart Association, (2019) 8(7), e011581.
39. A. Kuś, E. Marouli, M. F. Del Greco L. Chaker, T. Bednarczuk, R. P. Peeters, P. Deloukas, Variation in normal range thyroid function affects serum cholesterol levels, blood pressure, and type 2 diabetes risk: a mendelian randomization study. Thyroid, (2021) 31(5), 721-731.
40. M. L. Morieri, V. Perrone, C. Veronesi, L. Degli Esposti, M. Andretta, M. Plebani, A. Avogaro, Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetes. Cardiovascular diabetology, (2021) 20(1), 1- 12.
41. R. Galiero, A. Caturano, E. Vetrano, A. Cesaro, L. Rinaldi, T. Salvatore, F. C. Sasso, Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease. Reviews in cardiovascular medicine, (2021) 22(3), 755- 768.
42. E. Bahiru, R. Hsiao, D. Phillipson, K. E. Watson, Mechanisms and treatment of dyslipidemia in diabetes. Current Cardiology Reports, (2021) 23(4), 1-6.
43. X. Xuan, M. Hamaguchi, Q. Cao, T. Okamura, Y. Hashimoto, A. Obora, X. Xie, U-shaped association between the triglyceride-glucose index and the risk of incident diabetes in people with normal glycemic level: A population-base longitudinal cohort study. Clinical Nutrition, (2021) 40(4), 1555-1561.
44. L. A. Rodriguez, P. T. Bradshaw, S. C. Shiboski, A. Fernandez, E. Vittinghoff, D. Herrington, A. M. Kanaya, Examining if the relationship between BMI and incident type 2 diabetes among middle– older aged adults varies by race/ethnicity: evidence from the Multi‐Ethnic Study of Atherosclerosis (MESA). Diabetic Medicine, (2021). 38(5), e14377.
45. C. Dannecker, R. Wagner, A. Peter, J. Hummel, A. Vosseler, H. U. Häring, M. Heni, Low-density lipoprotein cholesterol is associated with insulin secretion. The Journal of Clinical Endocrinology & Metabolism, (2021) 106(6), 1576-1584.
46. Margiana, Ria, et al. "Functions and therapeutic interventions of non-coding RNAs associated with TLR signaling pathway in atherosclerosis." Cellular Signalling 100 (2022): 110471.
47. Arif, Anam, et al. "The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer." International Immunopharmacology 114 (2023): 109581.
48. Lafta, Holya A., et al. "Tumor-Associated Macrophages (TAMs) in Cancer Resistance; Modula-tion by Natural Products." Current topics in medicinal chemistry (2023).
49. Lei, Zimeng, et al. "Detection of abemaciclib, an anti-breast cancer agent, using a new electrochemical DNA biosensor." Frontiers in Chemistry 10 (2022): 980162.
50. Hjazi, Ahmed, et al. "Unraveling the Impact of 27-Hydroxycholesterol in Autoimmune Diseases: Exploring Promising Therapeutic Approaches." Pathology-Research and Practice (2023): 154737.
51. Gupta, Jitendra, et al. "Double-edged sword role of miRNA-633 and miRNA-181 in human cancers." Pathology-Research and Practice (2023): 154701.
52. Hjazi, Ahmed, et al. "The pathological role of CXC chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics." Pathology-Research and Practice (2023): 154616.
53. Sane, Shahryar, et al. "Investigating the effect of pregabalin on postoperative pain in non-emergency craniotomy." Clinical Neurology and Neurosurgery 226 (2023): 107599.
54. Alwan, Nathera Hussin, et al. "The Effectiveness of Semantic Therapy on Death Anxiety, Pain Catastrophizing, Chronic Pain Acceptance, and Pain Intensity in Patients with Breast Cancer." International Journal of Body, Mind & Culture (2345-5802) 9 (2022).
2. E. Oktaviana, B. Nadrati, A. Fitriani, Analysis of the Relationship of Blood Glucose Levels with Total Cholesterol and Age of Diabetes Mellitus Patients. International Journal of Nursing and Health Services, (2022) 5(2), 195-202.
3. Y. Shan, Y., Q. Wang, Q., Y. Zhang, Y., X. Tong, X., S. Pu, S., Y. Xu, Y., X. Gao, High remnant cholesterol level is relevant to diabetic retinopathy in type 2 diabetes mellitus. Lipids in health and disease, (2022) 21(1), 1-10.
4. I. H. Seo, I. H., D. H. Son, D. H., H. S. Lee, H. S., Y. J. Lee, Non-HDL cholesterol as a predictor for incident type 2 diabetes in community-dwelling adults: longitudinal findings over 12 years. Translational Research, (2022) 243, 52-59.
5. G. Yang, G., T. Qian, T., H. Sun, H., Q. Xu, Q., X. Hou, X., W. Hu, Y. Wang, Both low and high levels of low-density lipoprotein cholesterol are risk factors for diabetes diagnosis in Chinese adults. Diabetes Epidemiology and Management, (2022) 100050.
6. G. Ouchi, G., I. Komiya, I., S. Taira, S., T. Wakugami, Y. Ohya, Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients. Lipids in Health and Disease, (2022) 21(1), 1-12.
7. C. I. Mercado, K. McKeever Bullard, E. W. Gregg, M. K. Ali, S. H. Saydah, G. Imperatore, Differences in US Rural-Urban Trends in Diabetes ABCS, 1999–2018. Diabetes Care, (2021) 44(8), 1766-1773.
8. M. M. Pathirana, Z. Lassi, A. Ali, M. Arstall, C. T. Roberts, P. H. Andraweera, Cardiovascular risk factors in women with previous gestational diabetes mellitus: A systematic review and meta- analysis. Reviews in Endocrine and Metabolic Disorders, (2021) 22(4), 729-761.
9. C. Perego, L. Da Dalt, A. Pirillo, A. Galli, A. L. Catapano, G. D. Norata, Cholesterol metabolism, pancreatic β-cell function and diabetes. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, (2019) 1865(9), 2149-2156.
10. Q. Zhang, Q., M. Zhang, M., Y. Chen, Y., Y. Cao, Y., G. Dong, Nonlinear Relationship of Non- High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011–2014). Journal of Alzheimer's Disease, (Preprint), (2022) 1-10.
11. F. Chen, F., B. Liu, Sleeve gastrectomy suppresses hepatic de novo cholesterogenesis and improves hepatic cholesterol accumulation in obese rats with type 2 diabetes mellitus. Nutrition, (2022) 94, 111531.
12. J. J. Belch, M. Brodmann, I. Baumgartner, C. J. Binder, M. Casula, C. Heiss, L. Tokgözoğlu, Lipid- lowering and anti-thrombotic therapy in patients with peripheral arterial disease. Vasa, (2021) 50(6), 401-411.
13. N. G. Gogolashvili, R. A. Yaskevich, Effectiveness of lipid-lowering therapy in outpatients with coronary artery disease living in a large industrial center of Eastern Siberia. Journal: Cardiovascular Therapy and Prevention, (2022) (8), 3135.
14. T. Onat, M. Demir Caltekin, V. A. Turksoy, E. Baser, D. Aydogan Kirmizi, M. Kara, E. S. Yalvac, The relationship between heavy metal exposure, trace element level, and monocyte to HDL cholesterol ratio with gestational diabetes mellitus. Biological Trace Element Research, (2021) 199(4), 1306-1315.
15. C. Caussy, A. Aubin, R. Loomba, The relationship between type 2 diabetes, NAFLD, and cardiovascular risk. Current diabetes reports, (2021) 21(5), 1-13.
16. Y. H. Seo, H. Y. Shin, Relationship between hs-CRP and HbA1c in Diabetes Mellitus Patients: 2015–2017 Korean National Health and Nutrition Examination Survey. Chonnam medical journal, (2021) 57(1), 62.
17. M. Shi, C. Wang, H. Mei, M. Temprosa, J. C. Florez, M. Tripputi, Diabetes Prevention Program Research Group. Genetic Architecture of Plasma Alpha‐Aminoadipic Acid Reveals a Relationship with High‐Density Lipoprotein Cholesterol. Journal of the American Heart Association, (2021) e024388.
18. H. Hussain, F. H. Wattoo, M. H. S. Wattoo, M. Gulfraz, T. Masud, I. Shah, S. E. Alavi, Camel milk as an alternative treatment regimen for diabetes therapy. Food Science & Nutrition, (2021) 9(3), 1347- 1356.
19. T. Qian, H. Sun, Q. Xu, et al. J Hum Hypertens, 35 (11):1020–8 (2021).
20. E. M. Yubero-Serrano, J. F. Alcalá-Diaz, F. M. Gutierrez-Mariscal, A. P. Arenas-de Larriva, P. J. Peña-Orihuela, R. Blanco-Rojo, J. Lopez-Miranda, Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study. Cardiovascular Diabetology, (2021) 20(1), 1-10.
21. A. von Eckardstein, Beyond HDL-Cholesterol: The Search for Functional Biomarkers of High Density Lipoproteins. CardioMetabolic Syndrome Journal, (2022) 2(1), 28-38.
22. D. Flood, J. A. Seiglie, M. Dunn, S. Tschida, M. Theilmann, M. E. Marcus, J. Manne-Goehler, The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults. The Lancet Healthy Longevity, (2021) 2(6), e340-e351.
23. T. Hidayat, B. Wiboworini, The Effect of Nutrition Support of Commercial Formula and FortemDia_Tri on Total Cholesterol Level and Blood Pressure in Type 2 Diabetes Mellitus Patients. In International Conference on Health and Medical Sciences (2021), 71-76. Atlantis Press.
24. Y. Ikegami, Y. Takenaka, D. Saito, A. Shimada, I. Inoue, Anagliptin Monotherapy for Six Months in Patients with Type 2 Diabetes Mellitus and Hyper-Low-Density Lipoprotein Cholesterolemia Reduces Plasma Levels of Fasting Low-Density Lipoprotein Cholesterol and Lathosterol: A Single- Arm Intervention Trial. Journal of Clinical Medicine Research, (2021) 13(10-11), 502.
25. R. Gupta., A. Ghosh., A. S. Kumar., A. Misra., Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Clinical Research & Reviews, (2020) vol. 14, no. 3, pp. 211-212.
26. A. S. Xiang, B. A. Kingwell, Rethinking good cholesterol: a clinicians' guide to understanding HDL. The Lancet Diabetes & Endocrinology, (2019) 7(7), 575-582.
27. E. M. Yubero-Serrano, J. F. Alcalá-Diaz, F. M. Gutierrez-Mariscal, A. P. Arenas-de Larriva, P. J. Peña-Orihuela, R. Blanco-Rojo, J. Lopez-Miranda, Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study. Cardiovascular Diabetology, (2021) 20(1), 1-10.
28. S. A. Husen, S. P. A. Wahyuningsih, A. N. M. Ansori, S. Hayaza, R. J. K. Susilo, W. Darmanto, D. Winarni, The effect of okra (Abelmoschus esculentus Moench) pods extract on malondialdehyde and cholesterol level in STZ-induced diabetic mice. Ecology, Environment and Conservation, (2019) 25(4), S50-S56.
29. T. Jojima, S. Sakurai, S. Wakamatsu, T. Iijima, M. Saito, T. Tomaru, Y. Aso, Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol. International Journal of Cardiology, (2021) 331, 243-248.
30. A. Viktorinova, D. Malickova, K. Svitekova, S. Choudhury, M. Krizko, Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes. Diabetes Research and Clinical Practice, (2021) 176, 108858.
31. S. Lee, J. Zhou, C. L. Guo, W. T. Wong, T., Liu, I. C. K. Wong, G. Tse, Predictive scores for identifying patients with type 2 diabetes mellitus at risk of acute myocardial infarction and sudden cardiac death. Endocrinology, diabetes & metabolism, (2021) 4(3), e00240.
32. M. Z. Kocak, G. Aktas, E. Erkus, I. Sincer, B. Atak, T. Duman, Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Revista da Associação Médica Brasileira, (2019) 65, 9-15.
33. R. Amelia, M. D. Sari, V. Virgayanti, R. A. Ariga, M. S. Harahap, Effect of duration of illness and lipid profile of type 2 Diabetes Mellitus patients on diabetic retinopathy. In IOP Conference Series: Earth and Environmental Science, (2021) (Vol. 713, No. 1, p. 012058). IOP Publishing.
34. P. Zhuang, F. Wu, L. Mao, F. Zhu, Y. Zhang, X. Chen, Y. Zhang, Egg and cholesterol consumption and mortality from cardiovascular and different causes in the United States: A population-based cohort study. PLoS medicine, (2021) 18(2), e1003508.
35. B. Rathsman, J. Haas, M. Persson, J. Ludvigsson, A. M. Svensson, M. Lind, T. Nyström, LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study. Journal of internal medicine, (2021) 289(6), 873-886.
36. H. Zhao, C. Zheng, M. Zhang, S. Chen, The relationship between vitamin D status and islet function in patients with type 2 diabetes mellitus. BMC endocrine disorders, (2021) 21(1), 1-7.
37. B. J. Cochran, K. L. Ong, B. Manandhar, K. A. Rye, High density lipoproteins and diabetes. Cells, (2021). 10(4), 850.
38. S. U. Khan, H. Rahman, V. Okunrintemi, H. Riaz, M. S. Khan, S. Sattur, M. J. Blaha, Association of lowering low‐density lipoprotein cholesterol with contemporary lipid‐lowering therapies and risk of diabetes mellitus: a systematic review and meta‐analysis. Journal of the American Heart Association, (2019) 8(7), e011581.
39. A. Kuś, E. Marouli, M. F. Del Greco L. Chaker, T. Bednarczuk, R. P. Peeters, P. Deloukas, Variation in normal range thyroid function affects serum cholesterol levels, blood pressure, and type 2 diabetes risk: a mendelian randomization study. Thyroid, (2021) 31(5), 721-731.
40. M. L. Morieri, V. Perrone, C. Veronesi, L. Degli Esposti, M. Andretta, M. Plebani, A. Avogaro, Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetes. Cardiovascular diabetology, (2021) 20(1), 1- 12.
41. R. Galiero, A. Caturano, E. Vetrano, A. Cesaro, L. Rinaldi, T. Salvatore, F. C. Sasso, Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease. Reviews in cardiovascular medicine, (2021) 22(3), 755- 768.
42. E. Bahiru, R. Hsiao, D. Phillipson, K. E. Watson, Mechanisms and treatment of dyslipidemia in diabetes. Current Cardiology Reports, (2021) 23(4), 1-6.
43. X. Xuan, M. Hamaguchi, Q. Cao, T. Okamura, Y. Hashimoto, A. Obora, X. Xie, U-shaped association between the triglyceride-glucose index and the risk of incident diabetes in people with normal glycemic level: A population-base longitudinal cohort study. Clinical Nutrition, (2021) 40(4), 1555-1561.
44. L. A. Rodriguez, P. T. Bradshaw, S. C. Shiboski, A. Fernandez, E. Vittinghoff, D. Herrington, A. M. Kanaya, Examining if the relationship between BMI and incident type 2 diabetes among middle– older aged adults varies by race/ethnicity: evidence from the Multi‐Ethnic Study of Atherosclerosis (MESA). Diabetic Medicine, (2021). 38(5), e14377.
45. C. Dannecker, R. Wagner, A. Peter, J. Hummel, A. Vosseler, H. U. Häring, M. Heni, Low-density lipoprotein cholesterol is associated with insulin secretion. The Journal of Clinical Endocrinology & Metabolism, (2021) 106(6), 1576-1584.
46. Margiana, Ria, et al. "Functions and therapeutic interventions of non-coding RNAs associated with TLR signaling pathway in atherosclerosis." Cellular Signalling 100 (2022): 110471.
47. Arif, Anam, et al. "The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer." International Immunopharmacology 114 (2023): 109581.
48. Lafta, Holya A., et al. "Tumor-Associated Macrophages (TAMs) in Cancer Resistance; Modula-tion by Natural Products." Current topics in medicinal chemistry (2023).
49. Lei, Zimeng, et al. "Detection of abemaciclib, an anti-breast cancer agent, using a new electrochemical DNA biosensor." Frontiers in Chemistry 10 (2022): 980162.
50. Hjazi, Ahmed, et al. "Unraveling the Impact of 27-Hydroxycholesterol in Autoimmune Diseases: Exploring Promising Therapeutic Approaches." Pathology-Research and Practice (2023): 154737.
51. Gupta, Jitendra, et al. "Double-edged sword role of miRNA-633 and miRNA-181 in human cancers." Pathology-Research and Practice (2023): 154701.
52. Hjazi, Ahmed, et al. "The pathological role of CXC chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics." Pathology-Research and Practice (2023): 154616.
53. Sane, Shahryar, et al. "Investigating the effect of pregabalin on postoperative pain in non-emergency craniotomy." Clinical Neurology and Neurosurgery 226 (2023): 107599.
54. Alwan, Nathera Hussin, et al. "The Effectiveness of Semantic Therapy on Death Anxiety, Pain Catastrophizing, Chronic Pain Acceptance, and Pain Intensity in Patients with Breast Cancer." International Journal of Body, Mind & Culture (2345-5802) 9 (2022).
Published
19-09-2023
Statistics
14 Views | 4 Downloads
Citatons
How to Cite
Mohammed , M. A., S. H. Ali, and A. M. A. Al-ghareebawi. “Evaluation Cholesterol and Triglycerides Levels for Type One Diabetes Patients”. World Journal of Current Medical and Pharmaceutical Research, Vol. 5, no. 5, Sept. 2023, pp. 168-74, doi:10.37022/wjcmpr.v5i5.289.
Issue
Section
Research Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
